|
Video: What is a Stock Split?
|
|
Soleno Therapeutics develops and commercializes diagnostics, devices and therapeutics. Co.'s commercial product, CoSense End-Tidal Carbon Monoxide Monitor, aids in the detection of excessive hemolysis, a condition in which red blood cells degrade rapidly. Co. also develops and markets pulmonary resuscitation solutions for the inpatient and ambulatory neonatal markets. Co.'s NeoForce, Inc. subsidiary's main product is the NeoPip T-piece resuscitator and related consumable. Co.'s research and development efforts are focused on its Sensalyze Technology Platform. According to our SLNOW stock split history records, SLNOW has had 0 splits. | |
|
SLNOW (SLNOW) has 0 splits in our SLNOW stock split history database.
Looking at the SLNOW stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SLNOW shares, starting with a $10,000 purchase of SLNOW, presented on a split-history-adjusted basis factoring in the complete SLNOW stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/17/2014 |
|
End date: |
11/08/2019 |
|
Start price/share: |
$0.57 |
|
End price/share: |
$0.04 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-93.86% |
|
Average Annual Total Return: |
-42.91% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$613.95 |
|
Years: |
4.98 |
|
|
|
|
|